$GBLX
GB SCIENCES INC Stock $gblx

$gblx Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000143774921002961 Filed on February 16, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue	$0.00	$0.00	$0.00
YoY Change
Gross Profit	$0.00	$0.00	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin	$324.1K	$670.3K	$491.8K
YoY Change	-72.67%	-54.49%	-61.91%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.25K	$14.49K	$2.580K
YoY Change	-51.38%	-80.89%	-102.13%
% of Gross Profit
Operating Expenses	$324.1K	$670.3K	$491.8K
YoY Change	-72.67%	-54.49%	-61.91%
Operating Profit	-$324.1K	-$670.3K	-$491.8K
YoY Change	-72.67%	-54.49%	-61.91%
Interest Expense	-$35.47K	$167.1K	$410.9K
YoY Change	-78.67%	-39.84%	16.5%
% of Operating Profit
Other Income/Expense, Net	$35.85K	$40.69K	-$412.7K
YoY Change	-113.32%	-98.98%	58.71%
Pretax Income	-$323.8K	-$629.6K	-$904.5K
YoY Change	-91.07%	-124.87%	-41.69%
Income Tax	-$234.6K	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$478.9K	-$594.0K	-$805.5K
YoY Change	-94.45%	-144.18%	-69.98%
Net Earnings / Revenue
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	-$1.594K	$0.00	-$2.871K
COMMON SHARES
Basic Shares Outstanding	293.5M	281.0M	280.5M
Diluted Shares Outstanding		281.0M

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$793.0K	$771.1K	$545.0K
YoY Change	422.53%	1967.18%	542.71%
Cash & Equivalents	$793.0K	$771.1K	$545.0K
Short-Term Investments
Other Short-Term Assets	$2.751M	$2.125M	$2.016M
YoY Change	4417.67%	2452.99%	31.17%
Inventory	$0.00
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.544M	$2.896M	$6.911M
YoY Change	-49.38%	-7.35%	106.27%
LONG-TERM ASSETS
Property, Plant & Equipment	$25.02K	$28.15K	$31.28K
YoY Change	-33.84%	-99.72%	-99.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$5.530M	$5.677M	$5.767M
YoY Change	5944.17%	5844.67%	-59.07%
Total Long-Term Assets	$7.262M	$7.353M	$7.343M
YoY Change	-1.22%	-58.64%	-72.28%
TOTAL ASSETS
Total Short-Term Assets	$3.544M	$2.896M	$6.911M
Total Long-Term Assets	$7.262M	$7.353M	$7.343M
Total Assets	$10.81M	$10.25M	$14.25M
YoY Change	-24.71%	-50.97%	-52.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.412M	$1.457M	$2.347M
YoY Change	-26.17%	-27.13%	44.73%
Accrued Expenses	$957.9K	$1.111M	$1.205M
YoY Change	17.74%	136.76%	61.11%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Long-Term Debt Due	$3.595M	$3.726M	$6.428M
YoY Change	-36.95%	-25.39%	27.95%
Total Short-Term Liabilities	$8.598M	$9.031M	$13.14M
YoY Change	-21.01%	1.23%	39.4%
LONG-TERM LIABILITIES
Long-Term Debt	$292.4K	$283.9K	$0.00
YoY Change	-91.72%	-92.04%	-100.0%
Other Long-Term Liabilities	$3.389M	$3.430M	$3.465M
YoY Change	14949.38%	2907.19%	41.47%
Total Long-Term Liabilities	$3.682M	$3.714M	$3.465M
YoY Change	3.54%	0.92%	-43.19%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.598M	$9.031M	$13.14M
Total Long-Term Liabilities	$3.682M	$3.714M	$3.465M
Total Liabilities	$12.28M	$12.74M	$16.60M
YoY Change	-14.97%	1.14%	-32.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$103.9M	-$100.7M	-$100.1M
YoY Change	6.67%	13.39%
Common Stock	$31.53K	$28.38K	$28.05K
YoY Change	14.44%	4.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.474M	-$2.496M	-$2.350M
YoY Change
Total Liabilities & Shareholders Equity	$10.81M	$10.25M	$14.25M
YoY Change	-24.71%	-50.97%	-52.23%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q3
OPERATING ACTIVITIES
Net Income	-$478.9K	-$594.0K	-$805.5K
YoY Change	-94.45%	-144.18%	-69.98%
Depreciation, Depletion And Amortization	$17.25K	$14.49K	$2.580K
YoY Change	-51.38%	-80.89%	-102.13%
Cash From Operating Activities	-$932.0K	-$1.040M	$111.0K
YoY Change	302.75%	48.23%	-112.13%
INVESTING ACTIVITIES
Capital Expenditures	$33.32K	-$326.0K	$0.00
YoY Change	-308.25%	-2137.5%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$27.57K	$4.323M	$597.7K
YoY Change	72.31%	-43229700.0%	-329.32%
Cash From Investing Activities	$60.90K	$3.997M	$597.7K
YoY Change		24881.0%	-301.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.095M	-2.730M	-115.6K
YoY Change	216.7%	-504.66%	-109.92%
NET CHANGE
Cash From Operating Activities	-932.0K	-1.040M	111.0K
Cash From Investing Activities	60.90K	3.997M	597.7K
Cash From Financing Activities	1.095M	-2.730M	-115.6K
Net Change In Cash	224.3K	227.1K	593.0K
YoY Change	95.93%	-2108.05%	-1361.74%
FREE CASH FLOW
Cash From Operating Activities	-$932.0K	-$1.040M	$111.0K
Capital Expenditures	$33.32K	-$326.0K	$0.00
Free Cash Flow	-$965.4K	-$714.3K	$111.0K
YoY Change	348.13%	-0.49%	-112.63%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	gblx	Adjustment For New Lease Standard Period Of Adoption AdjustmentForNewLeaseStandardPeriodOfAdoption
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Registrant Name EntityRegistrantName	GB SCIENCES INC
	gblx	Adjustment For New Lease Standard Period Of Adoption AdjustmentForNewLeaseStandardPeriodOfAdoption	1227
	dei	Entity Shell Company EntityShellCompany	false
	dei	Entity Small Business EntitySmallBusiness	true
	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal	223094
	gblx	Accrued Interest Capitalized In Convertible Note Principal AccruedInterestCapitalizedInConvertibleNotePrincipal
	gblx	Accrued Interest Income AccruedInterestIncome
	gblx	Accrued Interest Income AccruedInterestIncome	50411
	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven	172500
	gblx	Accrued Liabilites Forgiven AccruedLiabilitesForgiven
CY2019Q4	gblx	Adjustments To Additional Paid In Capital Induced Note Conversion AdjustmentsToAdditionalPaidInCapitalInducedNoteConversion	127059
	gblx	Adjustments To Additional Paid In Capital Induced Note Conversion AdjustmentsToAdditionalPaidInCapitalInducedNoteConversion	127059
CY2020Q4	gblx	Adjustments To Additional Paid In Capital Modification Of Options And Warrants AdjustmentsToAdditionalPaidInCapitalModificationOfOptionsAndWarrants	57350
	gblx	Adjustments To Additional Paid In Capital Modification Of Options And Warrants AdjustmentsToAdditionalPaidInCapitalModificationOfOptionsAndWarrants	57350
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001165320
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	293521444
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	gblx	Amortization Of Discount On Note Receivable AmortizationOfDiscountOnNoteReceivable
	gblx	Amortization Of Discount On Note Receivable AmortizationOfDiscountOnNoteReceivable	120583
	gblx	Cancelled Shares Issued To Consultant Value CancelledSharesIssuedToConsultantValue
	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard
	gblx	Cumulative Effect Of New Lease Standard CumulativeEffectOfNewLeaseStandard	7550
CY2020Q4	gblx	Debt Default Penalty DebtDefaultPenalty
CY2019Q4	gblx	Debt Default Penalty DebtDefaultPenalty
	gblx	Debt Default Penalty DebtDefaultPenalty	286059
	gblx	Debt Default Penalty DebtDefaultPenalty
	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable	286059
	gblx	Default Penatly On Convertible Note Payable DefaultPenatlyOnConvertibleNotePayable
CY2020Q4	gblx	Working Capital Deficit WorkingCapitalDeficit	-6135112
CY2020Q1	gblx	Working Capital Deficit WorkingCapitalDeficit	-3884877
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1456695
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	1913049
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1110525
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	813618
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	98126152
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	97271157
	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	417616
	gblx	Depreciation Capitalized In Inventory DepreciationCapitalizedInInventory	370167
CY2020Q4	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	88743
CY2019Q4	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	115401
	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	224824
	gblx	Exercise Of Warrants For Stock Value ExerciseOfWarrantsForStockValue	965877
	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit	-650000
	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit
CY2020Q4	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit	-650000
CY2019Q4	gblx	Gain Loss On Amendment To Line Of Credit GainLossOnAmendmentToLineOfCredit
	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	372415
	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable
CY2020Q4	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable	372415
CY2019Q4	gblx	Gain Loss On Settlement Of Accounts Payable GainLossOnSettlementOfAccountsPayable
	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	319407
	gblx	Increase Decrease In Accrued Liabilities Excluding Interest Payable IncreaseDecreaseInAccruedLiabilitiesExcludingInterestPayable	169096
CY2019Q4	gblx	Incremental Common Shares Attributable To Potential Common Shares IncrementalCommonSharesAttributableToPotentialCommonShares	62735300
	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	17263
	gblx	Induced Dividend From Exercise Of Warrants InducedDividendFromExerciseOfWarrants	267525
CY2019Q4	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Induced Dividend From Warrant Exercises InducedDividendFromWarrantExercises
	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers
	gblx	Issuance Of Warrants To Brokers IssuanceOfWarrantsToBrokers	132914
	gblx	Operating Lease Interest Expense OperatingLeaseInterestExpense	1242
	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	45100
	gblx	Patent Filing And Drafting Costs Capitalized In Intangible Assets PatentFilingAndDraftingCostsCapitalizedInIntangibleAssets	163174
	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases
	gblx	Property Capitalized Under Operating Leases PropertyCapitalizedUnderOperatingLeases	182624
	gblx	Stock Options Issued For Services StockOptionsIssuedForServices	168000
	gblx	Stock Options Issued For Services StockOptionsIssuedForServices
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	46886
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	695932
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	196886
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	829736
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	63000
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	168000
CY2020Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	191500
CY2019Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32431
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	191500
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	241242
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	132914
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	776908
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	698615
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	131886787
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	158728095
CY2020Q4	us-gaap	Assets Assets	10248848
CY2020Q1	us-gaap	Assets Assets	14352868
CY2020Q4	us-gaap	Assets Current AssetsCurrent	2896166
CY2020Q1	us-gaap	Assets Current AssetsCurrent	7000880
CY2020Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	2084877
CY2020Q1	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	1755275
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	771064
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2406
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	771064
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19518
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	151766
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	182055
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	921357
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	37300
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	769591
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-144755
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	-129237
	us-gaap	Cash Provided By Used In Financing Activities Discontinued Operations CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations	529412
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-131302
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-446922
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	21098
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1533341
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	600000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	283819453
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	275541602
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	283819453
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	275541602
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	28382
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	27554
CY2020Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	283942
CY2020Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable
CY2020Q4	us-gaap	Cost Of Revenue CostOfRevenue
CY2019Q4	us-gaap	Cost Of Revenue CostOfRevenue
	us-gaap	Cost Of Revenue CostOfRevenue
	us-gaap	Cost Of Revenue CostOfRevenue
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1647376
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	525000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	608580
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	63058
CY2020Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	0
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	4502058
CY2020Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount
CY2019Q4	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	4502058
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	30097
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	100877
CY2019Q4	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	51608
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	5677156
CY2020Q1	us-gaap	Disposal Group Including Discontinued Operation Assets Noncurrent DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent	6185465
CY2020Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	150293
CY2019Q4	us-gaap	Disposal Group Including Discontinued Operation Cash And Cash Equivalents DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents	17782
CY2020Q4	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	331895
CY2020Q1	us-gaap	Due To Officers Or Stockholders Current DueToOfficersOrStockholdersCurrent	586512
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28968
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12287
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1128702
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	467872
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-216954
CY2020Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	467872
CY2019Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-92796
CY2020Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	670311
CY2019Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1472937
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1677482
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4555633
CY2020Q4	us-gaap	Gross Profit GrossProfit
CY2019Q4	us-gaap	Gross Profit GrossProfit
	us-gaap	Gross Profit GrossProfit
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Income Taxes Paid IncomeTaxesPaid
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	20961
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	485774
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	234564
	us-gaap	Gross Profit GrossProfit
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3243663
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1123473
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-629621
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2531453
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3009099
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1123473
CY2020Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-836311
CY2019Q4	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	2531453
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3243663
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1123473
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	0
CY2019Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0
CY2020Q4	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.01
	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2479
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-3359868
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	242327
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1547306
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	-0.01
CY2019Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
CY2020Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	-0.01
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	206690
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	234564
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-106385
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-254617
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	518892
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	291256
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	21449
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-204699
CY2019Q4	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	26648530
CY2019Q4	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	36086770
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense
	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	127059
CY2020Q4	us-gaap	Interest Expense InterestExpense	167120
CY2019Q4	us-gaap	Interest Expense InterestExpense	277813
	us-gaap	Interest Expense InterestExpense	1249994
	us-gaap	Interest Expense InterestExpense	942750
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	93931
CY2019Q4	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	51608
	us-gaap	Interest Paid Net InterestPaidNet	241014
	us-gaap	Interest Paid Net InterestPaidNet	451040
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	462930
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	366865
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.17
CY2020Q4	us-gaap	Liabilities Liabilities	12744924
CY2020Q1	us-gaap	Liabilities Liabilities	14441362
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	10248848
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	14352868
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9031278
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	10885757
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1115379
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	1406080
CY2020Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3429704
CY2020Q1	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	3555605
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2571850
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4642320
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-2442613
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	4112908
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4594621
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538784
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	4725923
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-91862
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1253180
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4248291
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-1274278
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2714950
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	-593984
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	1344474
	us-gaap	Net Income Loss NetIncomeLoss	-3246142
	us-gaap	Net Income Loss NetIncomeLoss	-3745234
CY2020Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
CY2019Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-360327
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-738107
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-593984
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1344474
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3246142
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3745234
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1396082
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-593984
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3246142
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3745234
CY2019Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	2531453
CY2020Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-836311
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-3243663
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-1123473
CY2019Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	2583061
CY2020Q4	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-836311
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-3243663
	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-1123473
CY2020Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	242327
CY2019Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-1186979
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-2479
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Basic NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic	-2621761
CY2019Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-1186979
CY2020Q4	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	242327
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-2479
	us-gaap	Net Income Loss From Discontinued Operations Available To Common Shareholders Diluted NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted	-2621761
CY2019Q4	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	8707650
	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	8707650
CY2019Q4	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	40000
	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	590000
CY2020Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	40690
CY2019Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4004390
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1331617
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3432160
CY2020Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	5224423
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	3726308
CY2020Q1	us-gaap	Notes Payable Current NotesPayableCurrent	5054728
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent
CY2020Q1	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	151923
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-670311
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-1472937
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1677482
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4555633
	us-gaap	Operating Lease Cost OperatingLeaseCost	3243
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2001
CY2020Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	17523
CY2019Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-127059
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	14149
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	89806
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	34500
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	175000
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	24983
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	175628
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	326000
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	91862
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	40225
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18776
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">Certain reclassifications have been made to the comparative period amounts to conform to the current period presentation. Certain items on the unaudited balance sheets and statements of operations and cash flows have been reclassified to conform with current period presentation. The assets, liabilities, income/(loss), and cash flows of GB Sciences Louisiana, LLC, GB Sciences Nevada, LLC, GB Sciences Las Vegas, LLC, and GB Sciences Nopah, LLC have been reclassified to discontinued operations due to the sale of the Company's Louisiana cultivation and extraction facility (Note <div style="display: inline; font-style: italic; font: inherit;">10</div>) and the pending sale of the Company's Nevada cultivation and extraction facilities (Note <div style="display: inline; font-style: italic; font: inherit;">11</div>).</div></div></div></div></div>
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	300000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	2630000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	790225
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	375000
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	5051923
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	249807
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1069975
CY2020Q4	us-gaap	Profit Loss ProfitLoss	-593984
CY2019Q4	us-gaap	Profit Loss ProfitLoss	984147
	us-gaap	Profit Loss ProfitLoss	-3246142
	us-gaap	Profit Loss ProfitLoss	-4483341
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	28150
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	37821
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	3156014
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	26664
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	151923
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100650610
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-97387205
CY2020Q4	us-gaap	Revenues Revenues
CY2019Q4	us-gaap	Revenues Revenues
	us-gaap	Revenues Revenues
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	280967623
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	280119116
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	253297660
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	263055254
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	280967623
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	280119116
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	253297660
	us-gaap	Revenues Revenues
	us-gaap	Share Based Compensation ShareBasedCompensation	248850
	us-gaap	Share Based Compensation ShareBasedCompensation	455242
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	18916334
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.19
CY2019Q4	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	245000
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	525000
CY2019Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214000
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	214000
CY2019Q4	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	240000
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	718697
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-2349571
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-2496076
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	14315663
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	8301983
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-88494
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	17155999
CY2020Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	827546
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	592982
	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Use of Estimates</div></div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period.  The Company regularly evaluates estimates and assumptions related to allowances for doubtful accounts, inventory valuation and standard cost allocations, valuation of initial right-of-use assets and corresponding lease liabilities, valuation of beneficial conversion features in convertible debt, valuation of the assets and liabilities of discontinued operations, stock-based compensation expense, purchased intangible asset valuations, deferred income tax asset valuation allowances, uncertain tax positions, litigation and other loss contingencies.  These estimates and assumptions are based on current facts, historical experience and various other factors that the Company believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the recording of costs and expenses that are <div style="display: inline; font-style: italic; font: inherit;">not</div> readily apparent from other sources. The actual results the Company experiences <div style="display: inline; font-style: italic; font: inherit;"> may </div>differ materially and adversely from these estimates.</div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	325790554

Files In Submission

Name	View Source	Status
0001437749-21-002961-index-headers.html	Edgar Link	pending
0001437749-21-002961-index.html	Edgar Link	pending
0001437749-21-002961.txt	Edgar Link	pending
0001437749-21-002961-xbrl.zip	Edgar Link	pending
ex_219802.htm	Edgar Link	pending
ex_219803.htm	Edgar Link	pending
ex_219804.htm	Edgar Link	pending
ex_219805.htm	Edgar Link	pending
ex_225314.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gblx-20201231.xml	Edgar Link	completed
gblx-20201231.xsd	Edgar Link	pending
gblx-20201231_cal.xml	Edgar Link	unprocessable
gblx-20201231_def.xml	Edgar Link	unprocessable
gblx-20201231_lab.xml	Edgar Link	unprocessable
gblx-20201231_pre.xml	Edgar Link	unprocessable
gblx20201231_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GBLX
GB SCIENCES INC Stock $gblx

2021 Q1 Form 10-Q Financial Statement

#000143774921002961 Filed on February 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX GB SCIENCES INC Stock $gblx

2021 Q1 Form 10-Q Financial Statement

#000143774921002961 Filed on February 16, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GBLX
GB SCIENCES INC Stock $gblx